Volume 6, Number 5

Objective Measures of Activity and Attention in the Differential Diagnosis of Psychiatric Disorders of Childhood
Attention-Deficit Hyperactivity Disorder (ADHD) and mood disorders are common childhood-onset conditions that can persist into adolescence and adulthood. Both are characterized by prominent disturbances in activity levels and behavior that can be attributed to hyperactivity and inattention. Read More

Integrated Pharmacologic Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
This article presents a comparison of the two most commonly used classes of stimulants: methylphenidate and amphetamine. The more complex approaches to therapy--including the simultaneous use of multiple medications--are also discussed Read More

Nonstimulant Therapies for Attention-Deficit Hyperactivity Disorder (ADHD) in Children and Adults
Nonstimulant pharmacological choices for ADHD comprise an important option for patients with this disorder. The only nonstimulant that has been approved by the FDA for ADHD--atomoxetine (Strattera)--is described, thereby broadening our view of pharmacologic the options for ADHD. Read More

Special Report
Treatment of Comorbidity in Conduct Disorder with Attention-Deficit Hyperactivity Disorder (ADHD)
The rate of comorbidity in conduct disorder (CD) is high, with attention-deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) being the most common. This article includes both pharmacologic and nonpharmacologic treatment options for this comorbidity in children. Read More

Interview
Discussion on Integrated Pharmacologic Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
An insightful interview with a discussion on the history of the diagnosis and treatment of this disorder. It details the often overlooked explanation of why the use of stimulants in hyperactive children so often leads not only to improved performance, but also to reduced hyperactivity. Read More